Andrew Ritter
Board Member
GT Biopharma, Inc. (GTBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Ritter
Andrew Ritter is recorded as Board Member at GT Biopharma, Inc. (GTBP). GT Biopharma, Inc. reported in an 8-K filed June 11, 2025 that Andrew Ritter resigned as member of the board of directors, effective June 9, 2025. GT Biopharma, Inc. reported in an 8-K filed May 13, 2025 that Andrew Ritter was appointed non-employee director, effective May 8, 2025.
“On June 9, 2025, Andrew Ritter resigned as a member of the board of directors (the "Board") of the Company and all committees thereof.”
“On May 8, 2025, the Board appointed Andrew Ritter as a non-employee director to fill one of the vacancies on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-08–present
-
2025-05-08–2025-06-09
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GT Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Anthony Cataldo CEO
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.